THE Pharmaceutical Society of Zambia (PSZ) has warned that the withdrawal of USAID funding from the health sector has created a $42 million gap in HIV treatment, which could lead to a crisis if not addressed in the 2026 national budget. In an interview, Wednesday, PSZ president Keegan Mwape said the government must urgently plan for the shortfall to avoid stockouts of life-saving commodities such as antiretroviral drugs (ARVs) and HIV test kits. “The withdrawal of funding by USAID will have a significant impact on the availability of HIV treatment because now the government needs to find the $42 million needed to fill that gap. As a country, we have made significant progress in fighting the HIV pandemic, and this...